Sources | Names Used |
---|---|
CTRPv2 | JQ-1:navitoclax (2:1 mol/mol) |
PharmacoGx | JQ-1:navitoclax (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ZNF10 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.006 |
mRNA | HIRIP3 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.006 |
mRNA | GPAM | CTRPv2 | pan-cancer | AAC | 0.094 | 0.006 |
mRNA | DCANP1 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.006 |
mRNA | NAA16 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.006 |
mRNA | CHST9 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.006 |
mRNA | CPS1 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.006 |
mRNA | TP53TG5 | CTRPv2 | pan-cancer | AAC | -0.096 | 0.006 |
mRNA | KBTBD12 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.006 |
mRNA | CCDC85B | CTRPv2 | pan-cancer | AAC | -0.094 | 0.006 |